ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness
ENDRA Life Sciences Inc. (NASDAQ: NDRA) is gaining increasing investor attention as the company advances its TAEUS® Liver imaging platform while simultaneously evaluating strategic alternatives aimed at maximizing shareholder value.…
